ANK3 divergent transcript (ANK3-DT)

ANK3 divergent transcript (ANK3-DT) is a long non-coding RNA (lncRNA) gene that is positioned divergently from the protein-coding ANK3 gene and does not encode a protein. No direct role as a therapeutic target, biomarker, or disease association has been reported for ANK3-DT in the accessible scientific literature or gene annotation databases. Information on molecular function, involvement in signaling, disease, or drug interactions for ANK3-DT is currently lacking. ANK3-DT is annotated as a non-coding RNA gene ("RNA Gene") and does not produce a protein. The entity is distinct from the protein-coding ANK3 (ankyrin-G), which has established roles in cellular scaffolding, neuronal development, and several diseases, including neuropsychiatric disorders and cardiovascular conditions. However, these findings pertain to "ANK3," not "ANK3-DT." Scientific databases such as GeneCards and BioGPS list ANK3-DT as an RNA gene with the descriptor "divergent transcript" and no attributed molecular function, pathways, or disease relevance. No drugs, therapeutic mechanisms, or biomarker roles involving ANK3-DT have been reported in the available literature and databases. There is no evidence that ANK3-DT is a protein, enzyme, receptor, or other typical therapeutic target class. The target name is not misspelled, but it is not a conventional therapeutic target, and attempts to attribute "target" roles or drug interactions to this entity would be scientifically incorrect given current knowledge. ANK3-DT is a long non-coding RNA gene, not a traditional drug target or receptor, and nearly all fields related to disease function, drugs, or biomarkers should be recorded as null. The entry is not technically misspelled but may be incorrect for drug targeting purposes due to its classification and lack of functional annotation.

Other names

ANK3-DT